Bristol-Myers Squibb Balance Sheet Health
Financial Health criteria checks 3/6
Bristol-Myers Squibb has a total shareholder equity of $16.5B and total debt of $55.7B, which brings its debt-to-equity ratio to 336.5%. Its total assets and total liabilities are $99.0B and $82.5B respectively. Bristol-Myers Squibb's EBIT is $8.3B making its interest coverage ratio 10.1. It has cash and short-term investments of $9.7B.
Key information
336.5%
Debt to equity ratio
US$55.68b
Debt
Interest coverage ratio | 10.1x |
Cash | US$9.67b |
Equity | US$16.55b |
Total liabilities | US$82.48b |
Total assets | US$99.03b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BMY's short term assets ($28.7B) exceed its short term liabilities ($25.8B).
Long Term Liabilities: BMY's short term assets ($28.7B) do not cover its long term liabilities ($56.7B).
Debt to Equity History and Analysis
Debt Level: BMY's net debt to equity ratio (278%) is considered high.
Reducing Debt: BMY's debt to equity ratio has increased from 39.3% to 336.5% over the past 5 years.
Debt Coverage: BMY's debt is well covered by operating cash flow (24.6%).
Interest Coverage: BMY's interest payments on its debt are well covered by EBIT (10.1x coverage).